Valiquette, Louis

Directeur de département, Faculté de médecine et des sciences de la santé
FMSS Dép. de microbiologie et infectiologie

Coordonnées

Courriel


819-821-8000, poste 72584

Diplômes

(2005) Master's non-Thesis (Master of Science). University of Toronto.

(2001) Diploma (Specialized medicine diploma). Université de Sherbrooke.

(1999) Diploma (Specialized medicine diploma). Université de Sherbrooke.

(1995) Doctorate (Doctor in medicine - M.D.). Université de Sherbrooke.

Titres de compétence

Certificat de spécialiste. Collège des médecins du Québec.

Certificat de spécialiste. Collège des médecins du Québec.

Certificat de spécialiste. Collège des médecins du Québec.

Fellow Royal College of Physicians of Canada. Royal College of Physicians and Surgeons of Canada.

Fellow Royal College of Physicians of Canada. Royal College of Physicians and Surgeons of Canada.

Présentation

Sujets de recherche

Bacterial Infections, Health Care Technologies, Health Prevention, Infectious Diseases, Pharmacoepidemiology.

Disciplines de recherche

Epidemiology and Biostatistics, Microbiology.

Mots-clés

Adult vaccines, Antimicrobial stewardship, Clostridium difficile, Medical informatics, Nosocomial infections, Pneumonia, Toxic Shock Syndrome.

Recherche clinique

Oui

Centre de recherche

Centre de recherche du CHUS

Langues parlées et écrites

Anglais, Français

Prix et distinctions

  • (2012) Chercheur-boursier clinicien, Junior 2 (passerelle). Centre Hospitalier Univ. de Sherbrooke. (Prize / Award).
  • (2010) Chercheur-boursier clinicien, Junior 1. Fonds de recherche du Québec - Santé (FRQS). (Prize / Award).
  • (2006) Bayer Healthcare Young Investigator Award. AMMI Canada. (Prize / Award).
  • CACMID Student Award. Canadian Association for Clinical Microbiology and Infectious Diseases. (Distinction).

Financement

Grant. (Awarded). Principal Applicant. Impact de l’intégration de la procalcitonine aux soins intensifs encadrée par l’utilisation d’un système expert bien établi au CIUSSS Estrie-CHUS, APSS.. (2017-2020).

Grant. (Awarded). Co-investigator. Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data. (2016-2020).

Grant. (Awarded). Principal Investigator. Epidemiology of Pneumococcal Pneumonia and Invasive Pneumococcal Diseases at the Centre Hospitalier Universitaire de Sherbrooke (1993-2008). (2010-2019).

Grant. (Awarded). Co-investigator. Canadian National Vaccine Safety Network (CANVAS) Influenza Safety Surveillance. (2017-2018).

Grant. (Awarded). Co-investigator. Sentinel surveillance for pneumococcal disease among hospitalized Canadian adults. (2016-2018).

Grant. (Awarded). Co-applicant. Development of serodiagnostic biomarkers for Candidemia. (2016-2017).

Grant. (Awarded). Co-investigator. SENTINEL SURVEILLANCE FOR SEVERE OUTCOMES OF LABORATORY- CONFIRMED INFLUENZA IN ADULTS FOR THE ANNUAL INFLUENZA SEASON. (2016-2017).

Publications

Articles de revue

  • Nichols MK , Andrew MK , Hatchette TF , Ambrose A , Boivin G , Bowie W , Chit A , Dos Santos G , ElSherif M , Green K , Haguinet F , Halperin SA , Ibarguchi B , Johnstone J , Katz K , Lagacé-Wiens P , Langley JM , LeBlanc J , Loeb M , MacKinnon-Cameron D , McCarthy A , McElhaney JE , McGeer A , Poirier A , Powis J , Richardson D , Schuind A , Semret M , Shinde V , Smith S , Smyth D , Stiver G , Taylor G , Trottier S , Valiquette L , Webster D , Ye L , McNeil SA , Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN), the Toronto Invasive Bacterial Diseases Network (TIBDN). (2018). Influenza vaccine effectiveness to prevent influenza-related hospitalizations and serious outcomes in Canadian adults over the 2011/12 through 2013/14 influenza seasons: A pooled analysis from the Canadian Immunization Research Network (CIRN) Serious. Vaccine, 36(16), 2166-2175. (Published).
  • Rochefort CM , Buckeridge DL , Tanguay A , Biron A , D'Aragon F , Wang S , Gallix B , Valiquette L , Audet LA , Lee TC , Jayaraman D , Petrucci B , Lefebvre P. (2017). Accuracy and generalizability of using automated methods for identifying adverse events from electronic health record data: a validation study protocol. BMC health services research, 17(1), 147. (Published).
  • Wilcox MH , Gerding DN , Poxton IR , Kelly C , Nathan R , Birch T , Cornely OA , Rahav G , Bouza E , Lee C , Jenkin G , Jensen W , Kim YS , Yoshida J , Gabryelski L , Pedley A , Eves K , Tipping R , Guris D , Kartsonis N , Dorr MB , MODIFY I and MODIFY II Investigators. (2017). Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. The New England journal of medicine, 376(4), 305-317. (Published).
  • Couture-Cossette A , Carignan A , Ilangumaran S , Valiquette L. (2017). Bezlotoxumab for the prevention of Clostridium difficile recurrence. Expert opinion on biological therapy, Epub ahead of print, 1-7. (Published).
  • LeBlanc JJ , ElSherif M , Ye L , MacKinnon-Cameron D , Li L , Ambrose A , Hatchette TF , Lang AL , Gillis H , Martin I , Andrew MK , Boivin G , Bowie W , Green K , Johnstone J , Loeb M , McCarthy A , McGeer A , Moraca S , Semret M , Stiver G , Trottier S , Valiquette L , Webster D , McNeil SA , Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). (2017). Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study. Vaccine, 35(29), 3647-3654. (Published).
  • Andrew MK , Shinde V , Hatchette T , Ambrose A , Boivin G , Bowie W , Chit A , Dos Santos G , ElSherif M , Green K , Haguinet F , Halperin SA , Ibarguchi B , Johnstone J , Katz K , Langley JM , LeBlanc J , Loeb M , MacKinnon-Cameron D , McCarthy A , McElhaney J , McGeer A , Nichols MK , Powis J , Richardson D , Semret M , Stiver G , Trottier S , Valiquette L , Webster D , Ye L , McNeil SA , Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN). (2017). Influenza vaccine effectiveness against influenza-related hospitalization during a season with mixed outbreaks of four influenza viruses: a test-negative case-control study in adults in Canada. BMC infectious diseases, 17(1), 805. (Published).
  • Ng C , Ye L , Noorduyn SG , Hux M , Thommes E , Goeree R , Ambrose A , Andrew MK , Hatchette T , Boivin G , Bowie W , ElSherif M , Green K , Johnstone J , Katz K , Leblanc J , Loeb M , MacKinnon-Cameron D , McCarthy A , McElhaney J , McGeer A , Poirier A , Powis J , Richardson D , Sharma R , Semret M , Smith S , Smyth D , Stiver G , Trottier S , Valiquette L , Webster D , McNeil SA , Serious Outcomes Surveillance Network of the Canadian Immunization Research Network (CIRN) Investigators , Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators. (2017). Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research Network. Influenza and other respiratory viruses, epub ahead of print, epub ahead of print. (Published).
  • Andrew MK , Shinde V , Ye L , Hatchette T , Haguinet F , Dos Santos G , McElhaney JE , Ambrose A , Boivin G , Bowie W , Chit A , ElSherif M , Green K , Halperin S , Ibarguchi B , Johnstone J , Katz K , Langley J , Leblanc J , Loeb M , MacKinnon-Cameron D , McCarthy A , McGeer A , Powis J , Richardson D , Semret M , Stiver G , Trottier S , Valiquette L , Webster D , McNeil SA , Serious Outcomes Surveillance Network of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN). (2017). The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly People. The Journal of infectious diseases, 216(4), 405-414. (Published).
  • Longtin Y , Garenc C , Valiquette L. (2016). Burden of Clostridium difficile Infections in Québec by Levy et al. Open forum infectious diseases, 3(3), ofw139. (Published).
  • Bédard E , Boppe I , Kouamé S , Martin P , Pinsonneault L , Valiquette L , Racine J , Prévost M. (2016). Combination of Heat Shock and Enhanced Thermal Regime to Control the Growth of a Persistent Legionella pneumophila Strain. Pathogens (Basel, Switzerland), 5(2), Epub. (Published).
  • Laupland KB , Valiquette L. (2016). Delusional Infestation. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale, 2016, 9091838. (Published).
  • Carignan A , Poulin S , Martin P , Labbé AC , Valiquette L , Al-Bachari H , Montpetit LP , Pépin J. (2016). Efficacy of Secondary Prophylaxis With Vancomycin for Preventing Recurrent Clostridium difficile Infections. The American journal of gastroenterology, Epub ahead of print, Epub ahead of print. (Published).
  • Bédard E , Lévesque S , Martin P , Pinsonneault L , Paranjape K , Lalancette C , Dolcé CÉ , Villion M , Valiquette L , Faucher SP , Prévost M. (2016). Energy Conservation and the Promotion of Legionella pneumophila Growth: The Probable Role of Heat Exchangers in a Nosocomial Outbreak. Infection control and hospital epidemiology, Epub ahead of print, 1-6. (Published).
  • Beaudoin M, Kabanza F, Nault V, and Valiquette L. (2016). Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs. Artificial Intelligence in Medicine, TBD, TBD. (Accepted).
  • Lee C , Louie TJ , Weiss K , Valiquette L , Gerson M , Arnott W , Gorbach SL. (2016). Fidaxomicin versus Vancomycin in the Treatment of Clostridium difficile Infection: Canadian Outcomes. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale, 2016, 8048757. (Published).
  • Nault V, Pépin J, Beaudoin M, Perron J, Moutquin JM, Valiquette L. (2016). Sustained Impact of a Computer-Assisted Antimicrobial Stewardship Intervention on AntimicrobialUse and Length of Stay. Journal of Antimicrobial Chemotherapy, NA, NA. (Accepted).
  • Martin P Laupland KB Frost EH Valiquette L. (2015). Laboratory diagnosis of Ebola virus disease. Intensive Care Med, 41(5), 895-8.
  • Valiquette L Sirard S Laupland K. (2014). A microbiological explanation for the obesity pandemic?. Can J Infect Dis Med Microbiol, 25(6), 294-5.
  • Beaudoin M, Kabanza F, Nault V, Valiquette L. (2014). An Antimicrobial Prescription Surveillance System that Learns from Experience. AI Magazine, 35(1), 1-8. (Published).
  • Laupland KB Valiquette L. (2014). Bill C-442: Shining the limelight on the Lyme-like?. Can J Infect Dis Med Microbiol, 25(5), 239-40.
  • Tom S , Galbraith JC , Valiquette L , Jacobsson G , Collignon P , Schønheyder HC , Søgaard M , Kennedy KJ , Knudsen JD , Ostergaard C , Lyytikäinen O , Laupland KB ,. (2014). Case fatality ratio and mortality rate trends of community-onset Staphylococcus aureus bacteraemia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 20, 630-2.
  • Laupland KB , Valiquette L. (2014). Ebola virus disease. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 25(3), 128-9. (Published).
  • Pépin J , Abou Chakra CN , Pépin E , Nault V , Valiquette L. (2014). Evolution of the global burden of viral infections from unsafe medical injections, 2000-2010. PloS one, 9(6), e99677.
  • Valiquette L , Chakra CN , Laupland KB. (2014). Financial impact of health care-associated infections: When money talks. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 25(2), 71-4.
  • Baillot A , Audet M , Baillargeon JP , Dionne IJ , Valiquette L , Rosa-Fortin MM , Abou Chakra CN , Comeau E , Langlois MF. (2014). Impact of physical activity and fitness in class II and III obese individuals: a systematic review. Obesity reviews : an official journal of the International Association for the Study of Obesity, 15, 721-39.
  • McNeil S , Shinde V , Andrew M , et al. (2014). Interim estimates of 2013/14 influenza clinical severity and vaccine effectiveness in the prevention of laboratory-confirmed influenza-related hospitalisation, Canada, February 2014. Euro surveillance : bulletin Européen sur les maladies transmissibles = European communicable disease bulletin, 19(9), E-pub.
  • Laupland KB , Valiquette L. (2014). Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 25(1), 9-10.
  • Laupland KB , Valiquette L. (2014). Management of severe infections: A time to keep a cool head or a hot topic for clinical trials?. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 25(1), 9-10.
  • Garneau JR , Valiquette L , Fortier LC. (2014). Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam. BMC infectious diseases, 14(1), Epub.
  • Abou Chakra CN , Pepin J , Sirard S , Valiquette L. (2014). Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review. PloS one, 9(6), e98400.
  • Valiquette L , Laupland KB. (2014). The cellulitis season is open. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 25(4), 184-5. (Published).
  • Sacri AS , De Serres G , Quach C , Boulianne N , Valiquette L , Skowronski DM. (2014). Transmission of Acute Gastroenteritis and Respiratory Illness from Children to Parents. The Pediatric infectious disease journal, 33, 583-8.
  • Valiquette L , Laupland KB. (2013). 10 years later. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 24(4), 175-6.
  • Bernard S , Valiquette L , De Wals P , Nault V , Babakissa C , Cyr C , Boileau TC , Gagneur A. (2013). Burden of rotavirus disease: A population-based study in Eastern Townships, Quebec. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 24(3), 138-42.
  • Masse V , Valiquette L , Boukhoudmi S , Bonenfant F , Talab Y , Carvalho JC , Alarie I , Carrier N , Farand P. (2013). Impact of methicillin resistant Staphylococcus aureus contact isolation units on medical care. PloS one, 8(2), Epub.
  • J Perron , M Gilbert , V Nault , M Beaudoin , L Valiquette. (2013). Optimiser la prescription d’antimicrobiens : une solution informatisée. Pharmactuel - La revue de l'association des pharmaciens du Québec (APES), 46(1), 40-45. (Published).
  • Laupland KB , Valiquette L. (2013). Outpatient parenteral antimicrobial therapy. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 24(1), 9-11.
  • Bossé D , Lemire C , Ruel J , Cantin AM , Ménard F , Valiquette L. (2013). Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection, 41(2), 579-582.
  • Valiquette L , Laupland KB. (2013). Something old, something new, something borrowed. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 24(2), 63-4.
  • Laupland KB , Valiquette L. (2013). The changing culture of the microbiology laboratory. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie médicale / AMMI Canada, 24(3), 125-8.
  • Laupland KB , Lyytikäinen O , Søgaard M , Kennedy KJ , Knudsen JD , Ostergaard C , Galbraith JC , Valiquette L , Jacobsson G , Collignon P , Schønheyder HC ,. (2013). The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 19(5), 465-71.
  • Wintenberger C, Barbut F, Berger P, Chidiac C, Collignon A, Eckert C, Rabaud C, Valiquette L, and Yazdanpanah Y. (2013). Un germe et sa prevention: Clostridium difficile. Medecin et Maladies Infectieuses, 43, 3-9. (Published).
  • Matthews P , Alpert M , Rahav G , Rill D , Zito E , Gardiner D , Pedersen R , Babinchak T , McGovern PC ,Tigecycline 900 cSSSI Study Group. (2012). A randomized trial of tigecycline versus ampicillin-sulbactam or amoxicillin-clavulanate for the treatment of complicated skin and skin structure infections. BMC infectious diseases, 12, epub.
  • Crook DW , Walker AS , Kean Y , Weiss K , Cornely OA , Miller MA , Esposito R , Louie TJ , Stoesser NE , Young BC , Angus BJ , Gorbach SL , Peto TE , Study 003/004 Teams. (2012). Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 55 Suppl 2, 93-103.
  • Cornely OA , Crook DW , Esposito R , Poirier A , Somero MS , Weiss K , Sears P , Gorbach S , OPT-80-004 Clinical Study Group. (2012). Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. The Lancet infectious diseases, 12(4), 281-9.
  • Carignan A , Roussy JF , Lapointe V , Valiquette L , Sabbagh R , Pépin J. (2012). Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?. European urology, 62(3), 453-9.
  • Abou Chakra CN , Pepin J , Valiquette L. (2012). Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PloS one, 7(1), e30258.
  • Pépin J , Gonzales M , Valiquette L. (2012). Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. The Journal of infection, 64(4), 387-390.
  • De Serres G , Gariépy MC , Coleman B et al. (2012). Short and long-term safety of the 2009 AS03-adjuvanted pandemic vaccine. PloS one, 7(7), e38563.
  • Laupland KB , Schønheyder HC , Østergaard C , Knudsen JD , Valiquette L , Galbraith J , Kennedy KJ , Gradel KO ,. (2011). Epidemiology of Haemophilus influenzae bacteremia: a multi-national population-based assessment. The Journal of infection, 62(2), 142-8.
  • Grenier C , Pépin J , Nault V , Howson J , Fournier X , Poirier MS , Cabana J , Craig C , Beaudoin M , Valiquette L. (2011). Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. The Journal of antimicrobial chemotherapy, 66(7), 1617-24.
  • Sirard S , Valiquette L , Fortier LC. (2011). Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. Journal of clinical microbiology, 49(12), 4040-6.
  • Tremblay J , Thibert L , Alarie I , Valiquette L , Pépin J. (2011). Nocardiosis in Quebec, Canada, 1988-2008. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 17(5), 690-6.
  • Pham-Huy A , Robinson JL , Tapiéro B , Bernard C , Daniel S , Dobson S , Déry P , Le Saux N , Embree J , Valiquette L , Quach C. (2010). Current trends in nontuberculous mycobacteria infections in Canadian children: A pediatric investigators collaborative network on infections in Canada (PICNIC) study. Paediatrics & child health, 15(5), 276-82.
  • Pépin J , Yared N , Alarie I , Lanthier L , Vanasse A , Tessier P , Deveau J , Chagnon MN , Comeau R , Cotton P , Libby SJ , Valiquette L. (2010). Klebsiella pneumoniae bacteraemia in a region of Canada. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 16(2), 141-6.

Chapitres de livre

  • Valiquette L Quach C. (2018). Antibiotic-Associated Diarrhea and Clostridium difficile infection. Pediatric Practice - Infectious Diseases McGraw Hill. (In Press).
  • Valiquette L. (2018). Clostridium difficile Infection in Adults. Evidence-Based Infectious DIseases Wiley & Sons. (In Press).
  • Valiquette L, Piché A. (2013). Infectiologie. Guide pratique de Médecine Interne Formed. (Published).
  • Valiquette L, Pépin J. (2011). Antibiotic-Associated Diarrhea. Pediatric Practice: Infectious Diseases McGraw-Hill. (Published).

Articles de journaux

  • Gagneur A , Lemaître T , Gosselin V , Farrands A , Carrier N , Petit G , Valiquette L , De Wals P. (2018). A postpartum vaccination promotion intervention using motivational interviewing techniques improves short-term vaccine coverage: PromoVac study. BMC public health. 811.

Rapports

  • Perras C, Tsakonas E, Ndegwa S, Conly J, Valiquette L, Farrah K. (2011). Vancomycin or Metronidazole for Treatment of Clostridium difficile Infection: Clinical and Economic Analyses. Canadian Agency for Drugs and Technologies in Health. 56 p.

Articles de conférence

  • Carignan A, Mercier A, Perron J, Nault V, Alarie I, Bergeron C, Beaudoin M, and Valiquette L. (2017). An offer you can’t refuse: clinical impact of accepting or rejecting a recommendation from an antibiotic stewardship program. IDWeek. (Published).
  • Abou Chakra CN, McGeer A, Labbé AC, Simor AE, Gold W, Muller MP, Powis J, Katz K, Cadarette S, Pépin J, Fortier LC, JR Garneau, and Valiquette L. (2017). Clostridium difficileDerivation and Validation of a Clinical Prediction Rule for Complications of Infection Using a Multicenter Prospective Cohort. IDWeek. (Published).
  • Beauregard-Paultre C, Abou Chakra CN, McGeer A, Labbé AC, Simor AE, Gold W, Muller MP, Powis J, Katz K, Cadarette S, Pépin J, Garneau JR, Valiquette L. (2017). Clostridium difficileExternal validation of predictive scores for mortality following infection. IDWeek. (Published).
  • Leblanc J, Elsherif M, Ye L, Mackinnon-Cameron D, Hatchette T, Lang A, Gillis H, Martin I, Ambrose A, Andrew MK, Boivin G, Bowie WR, Green K, Johnstone J, Loeb M, Mccarthy A, Mcgeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil S. (2017). Decrease in PCV13 Serotypes in Adults Hospitalized with Pneumococcal Pneumonia Over Time: Evidence of Herd Immunity Effects from Childhood Vaccination. IDWeek. (Published).
  • Elsherif M, Hatchette T, Leblanc J, Ye L, Andrew MK, Ambrose A, Boivin G, Bowie WR, Green K, Katz K, Loeb M, Mackinnon-Cameron D, Mccarthy A, McElhaney J, Mcgeer A, Nichols M, Powis J, Richardson D, Semret M, Smyth D, Trottier S, Valiquette L, Webster D and McNeil S. (2017). Epidemiology of Influenza Viruses in Canada over the 2011/2012 to 2013/2014 Seasons: A Study from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network(CIRN). IDWeek. (Published).
  • Andrew MK, Lees C, Godin J, Black K, McElhaney J, Ambrose A, Boivin G, Bowie WR, Elsherif M, Green K, Halperin SA, Hatchette T, Johnstone J, Katz K, Langley JM, Leblanc J, Lagace-Wiens P, Loeb M, Mackinnon-Cameron D, Mccarthy A, Mcgeer A, Powis J, RichardsonD , Semret M, Smith S, Smyth D, Taylor G, Trottier S, Valiquette L, Webster D, Ye L, McNeil S. (2017). Frailty Hinders Recovery From Acute Respiratory Illness in Older Adults. IDWeek. (Published).
  • Shaffelburg Z, Nichols M, Ye L, Andrew MK, Ambrose A, Boivin G, Bowie WR, Chit A, Dos Santos G, Elsherif M, Green K, Haguinet F, Halperin SA, Hatchette T, Ibarguchi B, Johnstone J, Katz K, Langley JM, Leblanc J, Lagace-Wiens P, Loeb M, Mackinnon-Cameron D, Mccarthy A, Mcelhaney J, Mcgeer A, Powis J, Richardson D, Semret M, Shinde V, Smith S, Smyth D, Taylor G, Trottier S, Valiquette L, Webster D, McNeil S. (2017). Impact of Antivirals in the Prevention of Serious Outcomes Associated with Influenza in Hospitalized Canadian Adults: A Pooled Analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). IDWeek. (Published).
  • Nichols M, Ye M, Andrew MK, Hatchette T, Ambrose A, Boivin G, Bowie WR, Dos Santos G, Elsherif M, Green K, Haguinet F, Katz K, Leblanc J, Loeb M, Mackinnon-Cameron D, Mccarthy A, Mcelhaney J, Mcgeer A, Powis J, Richardson D, Semret M, Sharma R, Shinde V, Smyth D, Trottier S, Valiquette L, Webster D, McNeil S. (2017). Impact of Prior Season Influenza Vaccination on Seasonal Influenza Vaccine Effectiveness: An Analysis over Four Consecutive Seasons from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). IDWeek. (Published).
  • MK Andrew, S MacDonald, L Ye, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie, A Chit, G Dos Santos, M ElSherif, K Green, T Hatchette, F Haguinet, S Halperin, B Ibarguchi, J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagace-Wiens, B Light; M Loeb, D MacKinnon-Cameron, A McCarthy, J McElhaney, A McGeer, A Poirier, J Powis, D Richardson,  M Semret, V Shinde, S Smith, D Smyth; G Stiver, G Taylor; S Trottier, L Valiquette, D Webster, S McNeil, and on behalf of the CIRN SOS Network Investigators and the TIBDN Investigators. (2016). Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season. Canadian Immunization Conference. (Accepted).
  • MK Andrew, S MacDonald, L Ye, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie, A Chit, G Dos Santos, M ElSherif, K Green, T Hatchette, F Haguinet, S Halperin, B Ibarguchi, J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagace-Wiens, B Light; M Loeb, D MacKinnon-Cameron, A McCarthy, J McElhaney, A McGeer, A Poirier, J Powis, D Richardson,  M Semret, V Shinde, S Smith, D Smyth; G Stiver, G Taylor; S Trottier, L Valiquette, D Webster, S McNeil, and on behalf of the CIRN SOS Network Investigators and the TIBDN Investigators. (2016). Impact of Frailty on Influenza Vaccine Effectiveness and Clinical Outcomes: Experience from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network 2011/12 Season. IDWeek. (Accepted).
  • M Nichols, L Ye, MK Andrew, T Hatchette, A Ambrose, G Boivin, W Bowie, G Dos Santos, M Elsherif, K Green, F Haguinet, K Katz, J Leblanc, M Loeb, D MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, J Powis, D Richardson, M Semret, R Sharma, V Shinde, D Smyth, S Trottier, L Valiquette, D Webster, and S McNeil on behalf of the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN). (2016). Impactof Prior Season Vaccination on Seasonal Influenza Vaccine Effectiveness. Canadian Immunization Conference. (Accepted).
  • Mulpur S, Li L, Ye L, Hatchette T, Andrew M, Ambrose A, Boivin G, Bowie W, Chit A, Dos Santos G, ElSherif M, Green K, Haguinet F, Halperin SA, Ibarguchi B, Johnstone J, Katz K, Langley JM, LeBlanc J, Lagacé-Wiens P, Light B, Loeb M, MacKinnon-Cameron D, McCarthy AE, McElhaney JE, McGeer, A, Poirier A, Powis J, Richardson D, Semret M, Shinde V, Smith S, Smyth D, Stiver G, Taylor G, Trottier S, Valiquette L, Webster D, McNeil SA, on behalf of the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN) and the Toronto Invasive Bacterial Diseases Network (TIBDN). (2016). Influenza Burden, Risk Factors for Severe Disease, and Influenza Vaccine Effectiveness among Patients with Chronic Obstructive Pulmonary Disease Admitted to Hospital with Lab-confirmed Influenza: A Study from the SOS Network of the CIRN. Canadian Immunization Conference. (Accepted).
  • S McNeil, T Hatchette, M Andrew, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie, A Chit, G Dos Santos, M ElSherif, K Green, F Haguinet, S Halperin, B Ibarguchi, J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagace-Wiens, B Light; M Loeb, D MacKinnon-Cameron, A McCarthy, J McElhaney, A McGeer, A Poirier, J Powis, D Richardson,  M Semret, V Shinde, S Smith, D Smyth; G Stiver, G Taylor; S Trottier, L Valiquette, D Webster, L Ye and on behalf of the CIRN SOS Network Investigators and the Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators. (2016). Influenza Vaccine Effectiveness in the Prevention of Influenza-related Hospitalization in Canadian Adults Over the 2011/12 through 2013/14 Season:A Pooled Analysis from the Serious Outcomes Surveillance Network of the CIRN. IDWeek. (Accepted).
  • Shelly A McNeil, MD, Todd Hatchette, MD, Melissa K Andrew, MD, PhD, Ardith Ambrose, RN, Guy Boivin, MD, MSc, Francisco Diaz-Mitoma, MD, PhD, William Bowie, MD, Ayman Chit, MBiotech, PhD, Gael Dos Santos, PhD, May Elsherif, MD, Karen Green, MSc, Francois Haguinet, MSc, Scott A Halperin, MD, Barbara Ibarguchi, MSc, Jennie Johnstone, MD, Kevin Katz, MD, CM, MSc, FRCPC, Joanne M Langley, MD, Jason Leblanc, PhD, Philippe Lagacé-Wiens, MD, Bruce Light, MD, Mark Loeb, MD, MSc, Donna Mackinnon-Cameron, MMath, Anne E Mccarthy, MD, Janet E McElhaney, MD, Allison McGeer, MD, MSc, Andre Poirier, MD, MSc, Jeff Powis, MD, MSc, David Richardson, MD, Makeda Semret, MD, Vivek Shinde, MD, MPH, Stephanie Smith, MD, MSc, Daniel Smyth, MD, Grant Stiver, MD, Geoff Taylor, MD, Sylvie Trottier, MD, Louis Valiquette, MD, MSc, Duncan Webster, MD, Lingyun Ye, PhD on behalf of the CIRN SOS Network Investigators and the Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators. (2016). Influenza vaccine effectiveness in the prevention of influenza-related hospitalization in Canadian adults over the 2011/12 through 2013/14 seasons: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of CIRN. Canadian Immunization Conference. (Accepted).
  • Carita Ng, Lingyun Ye, Stephen Noorduyn, Margaret Hux, Edward Thommes, Ron Goeree, Ardith Ambrose, Melissa K Andrew, Todd Hatchette, Guy Boivin, William Bowie, May ElSherif, Karen Green, Jennie Johnstone, Kevin Katz, Jason Leblanc, Mark Loeb, Donna MacKinnon-Cameron, Anne McCarthy, Janet E McElhaney, Allison McGeer, Andre Poirier, Jeff Powis, David Richardson, Makeda Semret, Rohita Sharma, Stephanie Smith, Daniel Smyth, Grant Stiver, Sylvie Trottier, Louis Valiquette, Duncan Webster, Shelly A McNeil; on behalf of the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network Investigators and the Toronto Invasive Bacterial Diseases Network (TIBDN) Investigators. (2016). Resource Utilization and Cost of Laboratory Confirmed Influenza Requiring Hospitalization in Canadian Adults. Canadian Immunization Conference. (Accepted).
  • SA McNeil, T Hatchette, M Andrew, A Ambrose, G Boivin, F Diaz-Mitoma, W Bowie, A Chit, G Dos Santos, M ElSherif, K Green, F Haguinet, SA Halperin, B Ibarguchi, J Johnstone, K Katz, JM Langley, J LeBlanc, P Lagacé -Wiens, B Light, M Loeb, D MacKinnon-Cameron, A McCarthy, JE McElhaney, A McGeer, M Nichols, A Poirier, J Powis, D Richardson, M Semret, V Shinde, S Smith, D Smyth, G Stiver, G Taylor, S Trottier, L Valiquette, D Webster, L Ye; on behalf of the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN). (2016). Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in Canadian seniors over the 2011/12 through 2013/14 season: A pooled analysis from the SOS Network. Canadian Immunization Conference. (Accepted).
  • Sheitoyan-Pesant C, Abou-Chakra Nour, Pépin Jacques, Marcil-Héguy A, Nault V, Valiquette L. (2014). Multiple recurrences : epidemiology and burden of Clostridium difficile infections. IDWeek. (Published).
  • Sirard S, Valiquette L, Grenier C, Langlois MF. (2014). Revisiting the obesity paradox : Impact of obesity on outcomes for patients with community-acquired pneumonia. Obesity Week. (Accepted).
  • Beaudoin M, Kabanza F, Nault V, Valiquette L. (2013). An Antimicrobial Prescription Surveillance System that Learns from Experience. Proceedings of the 25th Annual Conference on Innovative Applications of Artificial Intelligence (IAAI-13). (Accepted).
  • Nault V*, Beaudoin M, Perron J and Valiquette L. (2013). Antimicrobial Prescription Surveillance System (APSS): Delivering Maximum Results with Limited Resources. AMMI Canada Annual Meeting, Québec. First Prize Innovation Academy. (Accepted).
  • Nault V, Beaudoin M, Perron J and Valiquette L. (2013). Antimicrobial Prescription Surveillance System – APSS : A Persistent Impact after 20 Months of Use. IDWeek ; San Francisco, California. (Accepted).
  • McNeil S, et al. Public Health Agency of Canada/Canadian Institutes of Health Research (PCIRN) Serious Outcomes Surveillance Network Study. (2013). Burden of Community Acquired Pneumonia and Invasive Pneumococcal Disease amongst Hospitalized Canadian Adults. Options for the Control of Influenza VIII conference, Cape Town, South Africa. (Accepted).
  • Baillot A, Audet M, Abou Chakra C-N, Rosa-Fortin M-M, Dionne IJ, Comeau E, Méziat-Burdin A, Valiquette L, Baillargeon J-P, Langlois M-F. (2013). Does physical activity has benefits beyond weight loss in people with severe obesity? A systematic review. 20th European Congress on Obesity, London, UK. (Accepted).
  • McNeil S et al. Public Health Agency of Canada/ Canadian Institutes of Health Research (PCIRN) Serious Outcomes Surveillance Network Study. (2013). Effectiveness of 2011/12 Seasonal Influenza Vaccines in the Prevention of Influenza-related Hospitalization in Canadian Adults. Options for the Control of Influenza VIII conference, Cape Town, South Africa. (Accepted).
  • McNeil S, et al. Public Health Agency of Canada/ Canadian Institutes of Health Research (PCIRN) Serious Outcomes Surveillance Network Study. (2013). Effectiveness of 2012/13 Seasonal Influenza Vaccines in the Prevention of Influenza-related Hospitalization in Canadian Adults. Options for the Control of Influenza VIII conference, Cape Town, South Africa. (Accepted).
  • Ndaya-Tshibangu J, Valiquette L*, DeWals P, Lemaitre T, Petit G, Praud JP, Deceuninck G, Gagneur A. (2013). Effectiveness of pneumococcal heptavalent conjugate vaccine for the prevention of community-acquired pneumonia using a 2+1 infant schedule in Québec, Canada. IDWeek ; 2013 San Francisco, California. (Accepted).
  • Nault V*, Beaudoin M, Ersnt-Bissinger A and Valiquette L. (2013). How to Win the War on Bugs: EHR with Automated Antimicrobials Prescription Surveillance System. e-Health 2013: Accelerating Change, Ottawa, Canada. (Accepted).
  • Nault V, Beaudoin M, Perron J, Valiquette L. (2013). Impact d’un système d’optimisation de la prescription d’anti-infectieux au CHUS après 2 ans d’utilisation. 38ème Congrès annuel de l’AMMIQ; La Malbaie, Québec. (Accepted).
  • Beaudoin M, Kabanza F, Nault V, Valiquette L. (2013). Learning to Identify Inappropriate Antimicrobial Prescriptions. In Proceedings of 14th Conference on Artificial Intelligence in Medicine (AIME 2013), N. Peek, R. Marin, and N. Lavrac (Eds.), Sp. (Accepted).
  • Sirard S, Nault V, Langlois MF, Perron J, Beaudoin M, Valiquette L. (2013). Les prescriptions d’antimicrobiens sont inadéquates chez les patients obèses hospitalisés au CHUS. Les Médicaments et la Santé Publique (résumé RQRUM_S05). J Popul Ther Clin Pharmacol 20(3):e266-e304. (Accepted).
  • Tom S, Galbraith JC, Valiquette L, Jacobsson G, Collignon P, Schonheyder HC, Soogard M, Kennedy KJ, Knudsen JD, Ostergaard C, Lyytikainen O, Laupland KB. (2013). Mortality of Community-Onset Staphylococcus aureus Bacteremia: A Multi-National Population-Based Study. AMMI Canada Annual Meeting, Québec, Canada. (Accepted).
  • Abou Chakra CN, Labbé AC, McGeer A, Simor AE, Gold W, Devlin R, Katz K, Powis J, Fortier LC, Muller MP, Garneau JR, Pepin J, Valiquette L. (2013). Risk factors for complications of Clostridium difficile Infection in a prospective multicentre cohort. IDWeek, San Francisco, US. (Accepted).
  • McNeil S et al. - A Public Health Agency of Canada/Canadian Institutes of Health Research Serious Outcomes Surveillance Network Study (31 authors). (2013). Strain-specific influenza burden of disease among hospitalized Canadian adults during the 2011/12 season. Options for the Control of Influenza VIII conference, Cape Town, South Africa. (Accepted).
  • Barkati S, Savary Bélanger S, Filion F, Lavergne V, Su SH, Loungnarath V, Valiquette L, Lefebvre B, Weiss K and Labbé AC. (2013). Streptococcus pneumoniae Bloodstream Infection Among Patients with Hematological Malignancies: What is the Clinical Impact in an Era of Anti-pneumococcal Vaccination and Antibiotic Resistance?. AMMI Canada annual conference. (Accepted).
  • Barkati S, Savary Bélanger S, Filion F, Lavergne V, Su SA, Loungnarath V, Valiquette L, Lefebvre B, Weiss K, Labbé AC. (2013). Streptococcus pneumoniae Bloodstream Infection among Patients with Hematological Malignancies: Clinical Impact in an Era of Antipneumococcal Immunization and Antibiotic Resistance. IDWeek, San Francisco, US. (Accepted).
  • Louie T, Weiss K, Valiquette L and Gorbach S. (2013). The hypervirulent Clostridium difficile BI strain in Canada: incidence, type and comparative efficacy of fidaxomicin and vancomycin. AMMI Canada Annual Meeting, Quebec city, Canada. (Accepted).
  • Gariépy MC, De Serres G, Benoît M, McGeer A, McNeil S, McCarthy A, Valiquette L, Stiver G, Coleman B, Ou J, McIntyre P, Needham J, Bergeron C, Grenier C, Sleigh K, Giorgis N, Ambrose A, Bettinger. (2012). Active Electronic Surveillance of a Large Number of Health Care Workers (HCW) Following the Administration of the 2011-2012 Influenza Vaccine. 12ème Congrès Canadien sur la Vaccination (CIC), Vancouver, BC, Canada. (Accepted).
  • Abou Chakra N, Pepin J, Sirard S, and Valiquette L. (2012). A systematic review of risk factors for recurrences of Clostridium difficile infection. IDWeek ; San Diego, California. (Accepted).
  • Nault V, Sirard S, Langlois MF, Perron J, Beaudoin M, and Valiquette L. (2012). Inadequacy of Antibacterial Prescriptions in Obese and Morbidly Obese Adults. IDWeek ; 2012 ; San Diego, California. (Accepted).
  • Abou Chakra N, Labbé AC, McGeer A, Simor AE, Gold W, Muller M, Devlin R, Katz K, Powis J, Pépin J, and Valiquette L. (2012). Outcomes of Clostridium difficile Infection in Canadian Hospitals: A Prospective Cohort. IDWeek; San Diego, California, US. (Accepted).
  • Yale P, Masse V, McGeer A, Caan, D, Green K, Rudnick W, Fowler R, Adhikari N, Henzler D, Christian M, Herridge M, Valiquette L and Lamontagne F. (2011). Corticosteroid use in a cohort of ICU patients infected with influenza. American Thoracic Society International Conference; Denver, Colorado, É.U. (Accepted).
  • Valiquette L, Khuc NH, Grenier C, Pépin J et DeWals P. (2011). Impact du vaccin anti-pneumococcique conjugué sur les hospitalisations pour pneumonie de l’adulte à Sherbrooke. 36ème Congrès annuel de l’AMMIQ; 25-27 mai 2011, Montréal, Québec, Canada. (Accepted).
  • Nault V, Beaudoin M, Perron J, Pépin J,Valiquette L. (2011). Impact d’un système d’optimisation de la prescription d’agents antimicrobiens au CHUS. 36ème Congrès annuel de l’AMMIQ; Montreal, Québec. (Accepted).
  • Nault V, Beaudoin M, Perron J, Pépin J, Valiquette L. (2011). Impact of an antimicrobial stewardship program using a computerized surveillance system maximizing results with limited resources. Infectious Diseases Society of America 49th Annual Meeting; Boston, Massachusetts. (Accepted).
  • Benoit M, Gariépy M, Kallos A, Coleman B, Ambrose A, Rouleau I, McNeil S, McGeer A, Bettinger J, Valiquette L, McCarthy A, Stiver G, De Serres G, on behalf of the PHAC-CIHR Influenza Research Network. (2010). Safety of the 2010-2011 influenza vaccine in Health Care Workers (HCW) previously vaccinated in 2009 with adjuvanted pH1N1 vaccine. 9ème Congrès Canadien sur la Vaccination (CIC) ; Québec, Québec, Canada. (Accepted).
  • Gonzales M, Pepin J, Frost E, Carrier J, Sirard S et Valiquette L. (2010). Étude de la cinétique fécale de la vancomycine suite à son administration orale pour une suspicion d’infection à Clostridium difficile (ICD). 35ème Congrès annuel de l’AMMIQ; 26-28 mai 2010, Québec, Québec, Canada. (Accepted).

Autres contributions

Présentations

  • (2013). Doit-on toujours craindre les souches hypervirulentes 027 ?. Réunion Interdisciplinaire de Chimiothérapie Anti-infectieuse. Paris, France.
  • (2011). Adult Pneumococcal Disease in Canada: Current trends and Future Considerations. AMMI Canada Annual Conference. Montréal, Canada.
  • (2010). La vaccination des enfants contre le pneumocoque a-t-elle un impact pour la population adulte? (Président de séance et présentateur). 9e Congrès canadien sur l’immunisation. Quebec city, Canada.
  • (2010). Population based surveillance for bloodstream infections in Sherbrooke. 1st International expert meeting on Haemophilus influenzae. Calgary, Canada.
  • (2010). Prevention of Community-acquired Pneumonia in the Adult Population: Better Immunization Strategies are Needed. Drug Innovations Forum. toronto, Canada.

Les informations disponibles dans la base de données Expertus sont tirées du CV commun canadien.